P-70 First-in-human study of highly selective FGFR2 inhibitor, RLY-4008, in patients with intrahepatic cholangiocarcinoma and other advanced solid tumors
Title:
P-70 First-in-human study of highly selective FGFR2 inhibitor, RLY-4008, in patients with intrahepatic cholangiocarcinoma and other advanced solid tumors
Author:
Goyal, L. Subbiah, V. Mahipal, A. Kamath, S. Mody, K. Borad, M. El-Khoueiry, A. Sahai, V. Kim, R. Kelley, R. Schmidt-Kittler, O. Shen, J. Jen, K. Deary, A. Padval, M. Sherwin, C. Wolf, B. Schram, A.